Yvan Guindon

Dr. Guindon is a distinguished figure in bioorganic chemistry, serving as Research Director at IRCM and Full Professor at Université de Montréal. His groundbreaking research focuses on synthesizing therapeutic molecules through innovative stereoselective reactions involving free radicals, with applications ranging from antiviral agents to cardioprotective compounds. Noteworthy is his development of sialyl Lewis X (sLeX) mimetics for treating conditions like sickle-cell anemia and severe lung infections, including those associated with Covid-19. With extensive experience in both academia and industry, including leadership roles in prestigious organizations like RSC: The Academies of Arts, Humanities and Sciences of Canada, Dr. Guindon's contributions have garnered international recognition, evident through his memberships in esteemed scientific societies and numerous honors, including the Order of Canada and the Queen Elizabeth II’s Diamond Jubilee Medal.